Covered recipient · General Payments record
PALAK PATEL
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2020–2024
$3,128.51
- Reported across 52 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $893.23 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Ocular Therapeutix, Inc. | $172.20 | 1 |
| Genentech USA, Inc. | $144.63 | 2 |
| Genentech, Inc. | $141.15 | 1 |
| Astellas Pharma US Inc | $140.74 | 2 |
| Dutch Ophthalmic, USA | $135.24 | 1 |
| ABBVIE INC. | $66.35 | 4 |
| Regeneron Healthcare Solutions, Inc. | $51.05 | 2 |
| Harrow Eye, LLC | $23.07 | 1 |
| Bausch & Lomb Americas Inc. | $18.80 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.40 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105198280 | CMS |
| ABBVIE INC. | $17.19 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105198282 | CMS |
| ABBVIE INC. | $17.54 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105198284 | CMS |
| ABBVIE INC. | $16.22 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105198286 | CMS |
| Astellas Pharma US Inc | $16.64 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139307712 | CMS |
| Astellas Pharma US Inc | $124.10 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139425427 | CMS |
| Bausch & Lomb Americas Inc. | $18.80 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140423651 | CMS |
| Dutch Ophthalmic, USA | $135.24 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154792356 | CMS |
| Genentech USA, Inc. | $23.17 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133084636 | CMS |
| Genentech USA, Inc. | $121.46 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133084640 | CMS |
| Genentech, Inc. | $141.15 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133084644 | CMS |
| Harrow Eye, LLC | $23.07 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145611816 | CMS |
| Ocular Therapeutix, Inc. | $172.20 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148202315 | CMS |
| Regeneron Healthcare Solutions, Inc. | $23.74 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114132936 | CMS |
| Regeneron Healthcare Solutions, Inc. | $27.31 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114132938 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.